Category: Uncategorized
-
The ACTO Times Website Performance Report
Vijetha Karen Kitchley, M.Sc.International PhD Program in Cell Therapy and Regenerative MedicineTaipei Medical University Over the past three years, the ACTO Times website has demonstrated steady visibility and international reach, with a notable peak in engagement during 2025. Overall Traffic Between January 2024 and February 2026, the website recorded 2.6K total views and 1.1K visitors,…
-
Greeting from Editor-in Chief
THE ACTO TIMES: 2026 New Year EDITION Dear readers and friends of The ACTO Times, As we welcome the New Year 2026, I would like to extend my warmest greetings and sincere appreciation to everyone who has supported The ACTO Times. Your continued engagement through reading, submitting manuscripts, reviewing, and sharing our work has been…
-
Greetings from the ACTO chairperson
The ACTO times: 2026 New Year edition Akihiro Shimosaka Dear ACTO Members and Supporters, We are pleased to distribute the Volume 3 Issue 1 of The ACTO Times 2026 New Year Edition. Thank you for your continuous support of the journal as well as the overall activities of ACTO. ACTO annual meetings have already been held…
-
17th Annual ACTO Meeting
Welcome to the 17th Annual Meeting of the Asian Cellular Therapy Organization (ACTO), organized in collaboration with the Indonesian Stem Cell Association (ASPI). Since its establishment, the ACTO Annual Meeting has served as a premier scientific platform advancing cellular therapy and regenerative medicine across Asia. Over the years, the meeting has been successfully hosted in…
-
Gwo Xi’s stem cell product GXNPC1® shows safety and beneficial effect for stroke patients
Zhi Yong Chong, Chu Lin Tsai, Po Cheng Lin, Ming Hsi Chuang 1Gwo Xi Stem Cell Applied Technology Co., Ltd., Hsinchu, Taiwan, ROC *Corresponding author: genecold@gwoxi.com GXNPC1®, a novel autologous adipose-derived stem cell therapy for treating chronic stroke, focusing on angiogenesis, neural differentiation, and motor function improvement. ABSTRACT Gwo Xi Stem Cell Applied Technology Co.,…
-
Overview and Recommendations on Taiwan’s Exosome Market: EVs/exosome Definitions, Analytical Methods, and Application Scope
Youlin Wu 1,2 & Chih-hung Huang 11. Institute of Chemical Engineering, National Taipei University of Technology, Taipei, Taiwan.2. Prosperity Bio Co., Ltd., Taipei, Taiwan Introduction: Exosomes as an Emerging Hotspot with Market Chaos Since the 1990s, extracellular vesicles (EVs) were discovered to play immunological roles and to potentially mediate intercellular communication, which sparked a surge…
-
From Vision to Innovation: The Spirit of the Taiwan Future Technology Awards
Tony Yu-Xiu Lin, Thai-Yen Ling PhD.Graduate Institute of Pharmacology, National Taiwan University College of Medicine, Taiwan Each year, the Taiwan-based “Future Technology Awards” showcase and honour pioneering technologies with the potential to transform industries, societies and lives. According to the official information for the 2025 edition, the event is part of the Future Tech Pavilion 2025 held at…
-
The post-clinical trial development status of iPSC-derived platelets: Towards the application of the one-and-only universal product
Naoshi Sugimoto and Koji EtoCenter for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan Preface This year marks the 200th anniversary of the first successful blood transfusions by Dr. James Blundell, saving the lives of four women with severe postpartum bleeding. Today, regenerative medicine using iPSC-derived cells is entering clinical application. In 2020,…
-
Cartilage Cell–Sheet Transplantation for Osteoarthritis of the Knee: Toward a Disease‑Modifying, Joint‑Preserving Therapy
Masato SatoDepartment of Orthopaedic Surgery, School of Medicine, Tokai UniversityCenter for Musculoskeletal Innovative Research and Advancement (C-MIRA), Tokai University Graduate School Tokai University Institute of Medical Sciences Abstract Cartilage cell‑sheet engineering on temperature‑responsive culture surfaces preserves the extracellular matrix (ECM) and enables the sheet to adhere directly and uniformly to chondral defects without a scaffold.…
-
Cell Sheet Engineering for Cartilage Regeneration in Japan
Junko Matsuo & Setsuko HashimotoCellSeed Inc., Tokyo, Japan Abstract Cell sheet engineering has emerged as a powerful approach for cell therapy including cartilage regeneration. We summarize the feature of cell sheet using temperature-responsive cell cultureware, and its clinical application and highlight the regulatory frameworks of regenerative medicine in Japan. We also introduce our allogeneic chondrocyte…
THE ACTO TIMES 